Phase 1 Chronic Lung Disease Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction
Chronic Lung DiseaseLung Transplant Rejection
Instituto De Investigación Sanitaria Puerta De Hierro-Segovia De Arana12 enrolled1 locationNCT06514378
Active
Phase 1
A 3-part study consisting of a randomised, double-blind, placebo-controlled, single ascending dose study in healthy participants, followed by an open-labelled single dose LPS-challenge study in healthy participants and an open-labelled multiple dose study in COPD patients to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of EMP-012 for Injection Administered Subcutaneously.
Chronic Lung Disease
Empirico Inc.40 enrolled2 locationsACTRN12624000650594